Monday, December 23, 2024
HomeTagsSmall molecule therapeutics

small molecule therapeutics

Liminal BioSciences Announces Discontinuation of Fezagepras Development

Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") announced that it has discontinued development of fezagepras. The decision to discontinue the development of fezagepras is...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics